Vasospastic Angina: A Contemporary Review of its Pathophysiology, Diagnosis and Management [0.03%]
vasospastic心绞痛的病理生理、诊断和治疗的当代综述
Aish Sinha,Haseeb Rahman,Divaka Perera
Aish Sinha
Nearly 40% of patients presenting to the catheter laboratory with angina have non-obstructed coronary arteries (ANOCA), an umbrella term that encompasses distinct pathophysiological entities, such as coronary artery spasm. Coronary artery s...
Yu Horiuchi,Humberto Villacorta,Alan S Maisel
Yu Horiuchi
Heart failure (HF) is a complex syndrome with high mortality and hospitalization rates. Conventional care in patients with HF is usually based on clinical history and physical examination. Natriuretic peptides (NPs), B-type NP (BNP) and N-t...
Mavacamten: A First-in-class Oral Modulator of Cardiac Myosin for the Treatment of Symptomatic Hypertrophic Obstructive Cardiomyopathy [0.03%]
莫司卡替尼：一类首次口服型心脏肌球蛋白调节剂，用于治疗症状性肥厚梗阻性心肌病
Klevin Roger L Reyes,Gizem Bilgili,Florian Rader
Klevin Roger L Reyes
Hypertrophic cardiomyopathy is the most common monogenic cardiovascular disease that is caused by sarcomeric protein gene mutations. A hallmark of the most common form of the disease is outflow obstruction secondary to systolic narrowing of...
A Review of the Past, Present and Future of Cancer-associated Thrombosis Management [0.03%]
肿瘤相关血栓防治的过去、现在和未来综述
Randy K Ramcharitar,Louise Man,Minhaj S Khaja et al.
Randy K Ramcharitar et al.
Venous thromboembolism (VTE) can have a significant impact on the management, quality of life and mortality of patients with cancer. VTE occurs in 5-20% of patients with cancer, and malignancy is associated with up to 25% of all VTE. It is ...
Coronary Revascularization and Out-of-hospital Cardiac Arrest: Past, Present and Future [0.03%]
冠脉血运重建与院外心脏骤停：过去、现在和未来
Matthew E Li Kam Wa,Kalpa De Silva,Nilesh Pareek et al.
Matthew E Li Kam Wa et al.
Cardiologists and the cardiac catheter laboratory have key roles to play in the management of patients after out-of-hospital cardiac arrest (OHCA). Although immediate catheter laboratory activation is the standard of care in cardiogenic sho...
An Unusual Cause of Pacemaker Lead Displacement: 'Reverse Ratchet' Syndrome [0.03%]
起搏器导线移位的不寻常原因：“反向棘轮”综合征
Haytham Enab,Colin Cunnington,Amir Zaidi
Haytham Enab
Lead displacement is a common complication of pacemaker device implantation, often resulting in prolonged hospital stays and increased costs. The frequency of long-term lead displacement ranges between 1.8% and 8.0%. In our case, the patien...
A Narrative Review of Ultrathin-strut Drug-eluting Stents: The Thinner the Better? [0.03%]
超薄 strut 药物洗脱支架：越薄越好？一项叙述性研究
Maik J Grundeken,Marcel Am Beijk
Maik J Grundeken
Second-generation drug-eluting stents (DES) are considered standard of care for revascularization of patients undergoing percutaneous coronary intervention. Besides the polymer and antiproliferative drug used, the metallic backbone of DES i...
Endoleak after Endovascular Abdominal Aortic Aneurysm Repair Treated by Bilateral Transradial Access: Case Report [0.03%]
经双侧桡动脉途径治疗内脏期腹主动脉瘤修复术后内漏1例报告
Gustavo A Samaja,Heber Tejerina Segovia,José M Escalante et al.
Gustavo A Samaja et al.
The treatment of endovascular leaks after endovascular abdominal aortic repair can be challenging, particularly in patients with a lack of vascular access. We describe the case of a critically ill elderly patient with an endoleak resulting ...
Side Branch is the Main Determinant Factor of Bifurcation Lesion Complexity: Critical Review with a Proposal Based on Single-centre Experience [0.03%]
sidelines决定分叉病变复杂程度的决定性因素：基于单中心经验的评论与建议
Imad Sheiban,Filippo Figini,Valeria Gasparetto et al.
Imad Sheiban et al.
Although bifurcation stenting can be often managed with a simple provisional approach, in some settings, more complex techniques are appropriate. Based on our clinical experience and on data from literature, we propose a simple algorithm th...
Tomoya T Hinohara,Michael J Reardon,Sachin S Goel
Tomoya T Hinohara
Mitral regurgitation (MR) is the most prevalent valvular heart disease globally. Mitral valve surgery is the gold-standard treatment for MR. However, a significant portion of patients with mitral valve disease are at high or prohibitive sur...